December 2023

CV6 Receive MHRA Approval for UK-Wide Trials

Congratulations to portfolio company, CV6 Therapeutics, (NI) Ltd. and, in particular, Robert D. Ladner, Ph.D. on this significant commercial milestone. We look forward to following developments with interest as the company commences its first-in-human clinical trial. Article taken from: CV6 Therapeutics Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial (yahoo.com) CV6 Therapeutics […]

CV6 Receive MHRA Approval for UK-Wide Trials Read More »

ABOUT US

Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority.

Clarendon Fund Managers Limited is authorised and regulated by the Financial Conduct Authority
The content of the information and materials on the Website and any other information and materials provided by or though CFM in connection with Co-Fund NI and associated investment opportunities and Investee Companies, including any financial promotion as defined in Financial Services and Markets as Act 2000(“FSMA”) constituted thereby, has not been approved by an authorised person within the meaning of FSMA. Reliance on the information provided in relation to any specific Investee Company or otherwise, including any financial promotion constituted thereby, for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

December 2023

CV6 Receive MHRA Approval for UK-Wide Trials

ABOUT US

ADDITIONAL LINKS